[Current possibilities in the antiphlogistic and immunosuppressive therapy of progressive chronic polyarthritis].
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002908:Chronic Disease; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use; D007269:Injections, Intra-Arterial; D010396:Penicillamine / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011720:Pyrazoles; D012459:Salicylates; D006046:Gold; D010396:Penicillamine; D007213:Indomethacin
Gegenwärtige Möglichkeiten der antiphlogistisch-immunsuppressiven Behandlung der progressiv chronischen Polyarthritis.